IL-10 restricts activation-induced death of NK cells during acute murine cytomegalovirus infection

Journal of Immunology

Volumn 187, Issue 6, 2011, Pages 2944-2952

  Stacey, Maria A ^a   Marsden, Morgan ^a   Wang, Eddie C Y ^a   Wilkinson, Gavin W G ^a   Humphreys, Ian R ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 10 RECEPTOR ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; VIRUS DNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOTOXICITY; ENZYME ACTIVATION; IN VIVO STUDY; INNATE IMMUNITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS LOAD;

ANIMALS; APOPTOSIS; CELL SEPARATION; FLOW CYTOMETRY; HERPESVIRIDAE INFECTIONS; IMMUNITY, INNATE; INTERLEUKIN-10; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MUROMEGALOVIRUS; VIRAL LOAD;

EID: 80053069818     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101021     Document Type: Article

References (58)

1. See, D. M., P. Khemka, L. Sahl, T. Bui, and J. G. Tilles. 1997. The role of natural killer cells in viral infections. Scand. J. Immunol. 46: 217-224. (Pubitemid 27400224)
2. Biron, C. A., K. S. Byron, and J. L. Sullivan. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320: 1731-1735. (Pubitemid 19163129)
3. Lanier, L. L. 2008. Evolutionary struggles between NK cells and viruses. Nat. Rev. Immunol. 8: 259-268. (Pubitemid 351432802)
4. Bukowski, J. F., B. A. Woda, S. Habu, K. Okumura, and R. M. Welsh. 1983. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J. Immunol. 131: 1531-1538. (Pubitemid 13048919)
5. Gazit, R., B. Z. Garty, Y. Monselise, V. Hoffer, Y. Finkelstein, G. Markel, G. Katz, J. Hanna, H. Achdout, R. Gruda, et al. 2004. Expression of KIR2DL1 on the entire NK cell population: a possible novel immunodeficiency syndrome. Blood 103: 1965-1966. (Pubitemid 38269000)
6. O'Garra, A., F. J. Barrat, A. G. Castro, A. Vicari, and C. Hawrylowicz. 2008. Strategies for use of IL-10 or its antagonists in human disease. Immunol. Rev. 223: 114-131. (Pubitemid 351986180)
7. Moore, K. W., A. O'Garra, R. De Waal Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11: 165-190. (Pubitemid 23115005)
8. Mocellin, S., M. Panelli, E. Wang, C. R. Rossi, P. Pilati, D. Nitti, M. Lise, and F. M. Marincola. 2004. IL-10 stimulatory effects on human NK cells explored by gene profile analysis. Genes Immun. 5: 621-630. (Pubitemid 40045300)
9. Qian, C., X. Jiang, H. An, Y. Yu, Z. Guo, S. Liu, H. Xu, and X. Cao. 2006. TLR agonists promote ERK-mediated preferential IL-10 production of regulatory dendritic cells (diffDCs), leading to NK-cell activation. Blood 108: 2307-2315. (Pubitemid 44497514)
10. Cai, G., R. A. Kastelein, and C. A. Hunter. 1999. IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-γ when combined with IL-18. Eur. J. Immunol. 29: 2658-2665. (Pubitemid 30098990)
11. Carson, W. E., M. J. Lindemann, R. Baiocchi, M. Linett, J. C. Tan, C. C. Chou, S. Narula, and M. A. Caligiuri. 1995. The functional characterization of interleukin-10 receptor expression on human natural killer cells. Blood 85: 3577-3585.
12. Shibata, Y., L. A. Foster, M. Kurimoto, H. Okamura, R. M. Nakamura, K. Kawajiri, J. P. Justice, M. R. Van Scott, Q. N. Myrvik, and W. J. Metzger. 1998. Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFN-γ-inducing factors but enhances NK cell production of IFN-γ. J. Immunol. 161: 4283-4288. (Pubitemid 28469012)
13. Chiu, B. C., V. R. Stolberg, and S. W. Chensue. 2008. Mononuclear phagocyte-derived IL-10 suppresses the innate IL-12/IFN-γ axis in lung-challenged aged mice. J. Immunol. 181: 3156-3166.
14. Scott, M. J., J. J. Hoth, M. Turina, D. R. Woods, and W. G. Cheadle. 2006. Interleukin-10 suppresses natural killer cell but not natural killer T cell activation during bacterial infection. Cytokine 33: 79-86.
15. Couper, K. N., D. G. Blount, and E. M. Riley. 2008. IL-10: the master regulator of immunity to infection. J. Immunol. 180: 5771-5777.
16. McKinstry, K. K., T. M. Strutt, A. Buck, J. D. Curtis, J. P. Dibble, G. Huston, M. Tighe, H. Hamada, S. Sell, R. W. Dutton, and S. L. Swain. 2009. IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. J. Immunol. 182: 7353-7363.
17. Sun, J., R. Madan, C. L. Karp, and T. J. Braciale. 2009. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat. Med. 15: 277-284.
18. Sarangi, P. P., S. Sehrawat, S. Suvas, and B. T. Rouse. 2008. IL-10 and natural regulatory T cells: two independent anti-inflammatory mechanisms in herpes simplex virus-induced ocular immunopathology. J. Immunol. 180: 6297-6306.
19. Oakley, O. R., B. A. Garvy, S. Humphreys, M. H. Qureshi, and C. Pomeroy. 2008. Increased weight loss with reduced viral replication in interleukin-10 knock-out mice infected with murine cytomegalovirus. Clin. Exp. Immunol. 151: 155-164. (Pubitemid 350230986)
20. Madan, R., F. Demircik, S. Surianarayanan, J. L. Allen, S. Divanovic, A. Trompette, N. Yogev, Y. Gu, M. Khodoun, D. Hildeman, et al. 2009. Non-redundant roles for B cell-derived IL-10 in immune counter-regulation. J. Immunol. 183: 2312-2320.
21. Lee, S. H., K. S. Kim, N. Fodil-Cornu, S. M. Vidal, and C. A. Biron. 2009. Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection. J. Exp. Med. 206: 2235-2251.
22. Jones, M., K. Ladell, K. K. Wynn, M. A. Stacey, M. F. Quigley, E. Gostick, D. A. Price, and I. R. Humphreys. 2010. IL-10 restricts memory T cell inflation during cytomegalovirus infection. J. Immunol. 185: 3583-3592.
23. Humphreys, I. R., C. De Trez, A. Kinkade, C. A. Benedict, M. Croft, and C. F. Ware. 2007. Cytomegalovirus exploits IL-10-mediated immune regulation in the salivary glands. J. Exp. Med. 204: 1217-1225. (Pubitemid 46798163)
24. Brooks, D. G., M. J. Trifilo, K. H. Edelmann, L. Teyton, D. B. McGavern, and M. B. Oldstone. 2006. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12: 1301-1309. (Pubitemid 44706933)
25. Ejrnaes, M., C. M. Filippi, M. M. Martinic, E. M. Ling, L. M. Togher, S. Crotty, and M. G. Von Herrath. 2006. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 203: 2461-2472. (Pubitemid 44664616)
26. Kotenko, S. V., S. Saccani, L. S. Izotova, O. V. Mirochnitchenko, and S. Pestka. 2000. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc. Natl. Acad. Sci. USA 97: 1695-1700. (Pubitemid 30118505)
27. Hsu, D. H., R. De Waal Malefyt, D. F. Fiorentino, M. N. Dang, P. Vieira, J. De Vries, H. Spits, T. R. Mosmann, and K. W. Moore. 1990. Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 250: 830-832. (Pubitemid 120034310)
28. Brown, M. G., A. O. Dokun, J. W. Heusel, H. R. Smith, D. L. Beckman, E. A. Blattenberger, C. E. Dubbelde, L. R. Stone, A. A. Scalzo, and W. M. Yokoyama. 2001. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292: 934-937. (Pubitemid 32422491)
29. Arase, H., E. S. Mocarski, A. E. Campbell, A. B. Hill, and L. L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326. (Pubitemid 34522789)
30. Scalzo, A. A., N. A. Fitzgerald, A. Simmons, A. B. La Vista, and G. R. Shellam. 1990. Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J. Exp. Med. 171: 1469-1483. (Pubitemid 20167544)
31. Loh, J., D. T. Chu, A. K. O'Guin, W. M. Yokoyama, and H. W. Virgin IV. 2005. Natural killer cells utilize both perforin and γ interferon to regulate murine cytomegalovirus infection in the spleen and liver. J. Virol. 79: 661-667. (Pubitemid 39648423)
32. Tay, C. H., and R. M. Welsh. 1997. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 71: 267-275. (Pubitemid 26412288)
33. Orange, J. S., and C. A. Biron. 1996. An absolute and restricted requirement for IL-12 in natural killer cell IFN-γ production and antiviral defense: studies of natural killer and T cell responses in contrasting viral infections. J. Immunol. 156: 1138-1142.
34. Andrews, D. M., A. A. Scalzo, W. M. Yokoyama, M. J. Smyth, and M. A. Degli-Esposti. 2003. Functional interactions between dendritic cells and NK cells during viral infection. Nat. Immunol. 4: 175-181. (Pubitemid 36193020)
35. Andoniou, C. E., S. L. Van Dommelen, V. Voigt, D. M. Andrews, G. Brizard, C. Asselin-Paturel, T. Delale, K. J. Stacey, G. Trinchieri, and M. A. Degli-Esposti. 2005. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat. Immunol. 6: 1011-1019. (Pubitemid 41486186)
36. Dalod, M., T. Hamilton, R. Salomon, T. P. Salazar-Mather, S. C. Henry, J. D. Hamilton, and C. A. Biron. 2003. Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon a/b. J. Exp. Med. 197: 885-898. (Pubitemid 36437865)
37. Nguyen, K. B., T. P. Salazar-Mather, M. Y. Dalod, J. B. Van Deusen, X. Q. Wei, F. Y. Liew, M. A. Caligiuri, J. E. Durbin, and C. A. Biron. 2002. Coordinated and distinct roles for IFN-ab, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169: 4279-4287. (Pubitemid 35178200)
38. Orange, J. S., and C. A. Biron. 1996. Characterization of early IL-12, IFN-αβ, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156: 4746-4756. (Pubitemid 26174459)
39. Dokun, A. O., S. Kim, H. R. Smith, H. S. Kang, D. T. Chu, and W. M. Yokoyama. 2001. Specific and nonspecific NK cell activation during virus infection. Nat. Immunol. 2: 951-956. (Pubitemid 32976168)
40. Robbins, S. H., M. S. Tessmer, T. Mikayama, and L. Brossay. 2004. Expansion and contraction of the NK cell compartment in response to murine cytomegalovirus infection. J. Immunol. 173: 259-266. (Pubitemid 38797350)
41. Chiossone, L., J. Chaix, N. Fuseri, C. Roth, E. Vivier, and T. Walzer. 2009. Maturation of mouse NK cells is a 4-stage developmental program. Blood 113: 5488-5496.
42. Hayakawa, Y., and M. J. Smyth. 2006. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J. Immunol. 176: 1517-1524. (Pubitemid 43134295)
43. bright NK cells in treatment-naive HIV-1-seropositive individuals. J. Clin. Immunol. 22: 176-183.
44. Lehoux, M., A. Jacques, S. Lusignan, and L. Lamontagne. 2004. Murine viral hepatitis involves NK cell depletion associated with virus-induced apoptosis. Clin. Exp. Immunol. 137: 41-51. (Pubitemid 38869776)
45. + cells in life-threatening varicella. J. Infect. Dis. 191: 198-206.
46. Morishima, C., D. M. Paschal, C. C. Wang, C. S. Yoshihara, B. L. Wood, A. E. Yeo, S. S. Emerson, M. C. Shuhart, and D. R. Gretch. 2006. Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing. Hepatology 43: 573-580.
47. Shimozato, O., J. R. Ortaldo, K. L. Komschlies, and H. A. Young. 2002. Impaired NK cell development in an IFN-g transgenic mouse: aberrantly expressed IFN-γ enhances hematopoietic stem cell apoptosis and affects NK cell differentiation. J. Immunol. 168: 1746-1752. (Pubitemid 34135773)
48. Ross, M. E., and M. A. Caligiuri. 1997. Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response. Blood 89: 910-918. (Pubitemid 27121284)
49. Lee, S. W., S. Salek-Ardakani, R. S. Mittler, and M. Croft. 2009. Hypercostimulation through 4-1BB distorts homeostasis of immune cells. J. Immunol. 182: 6753-6762.
50. De Colvenaer, V., S. Taveirne, J. Hamann, A. M. De Bruin, M. De Smedt, T. Taghon, B. Vandekerckhove, J. Plum, R. Van Lier, and G. Leclercq. 2010. Continuous CD27 triggering in vivo strongly reduces NK cell numbers. Eur. J. Immunol. 40: 1107-1117.
51. Perona-Wright, G., K. Mohrs, F. M. Szaba, L. W. Kummer, R. Madan, C. L. Karp, L. L. Johnson, S. T. Smiley, and M. Mohrs. 2009. Systemic but not local infections elicit immunosuppressive IL-10 production by natural killer cells. Cell Host Microbe 6: 503-512.
52. Culley, F. J. 2009. Natural killer cells in infection and inflammation of the lung. Immunology 128: 151-163.
53. Stein-Streilein, J., M. Bennett, D. Mann, and V. Kumar. 1983. Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection. J. Immunol. 131: 2699-2704. (Pubitemid 14208817)
54. Grëgoire, C., L. Chasson, C. Luci, E. Tomasello, F. Geissmann, E. Vivier, and T. Walzer. 2007. The trafficking of natural killer cells. Immunol. Rev. 220: 169-182.
55. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47: 187-376. (Pubitemid 20010960)
56. Sumaria, N., S. L. Van Dommelen, C. E. Andoniou, M. J. Smyth, A. A. Scalzo, and M. A. Degli-Esposti. 2009. The roles of interferon-gamma and perforin in antiviral immunity in mice that differ in genetically determined NK-cell-mediated antiviral activity. Immunol. Cell Biol. 87: 559-566.
57. Walzer, T., M. Blëry, J. Chaix, N. Fuseri, L. Chasson, S. H. Robbins, S. Jaeger, P. Andrë, L. Gauthier, L. Daniel, et al. 2007. Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc. Natl. Acad. Sci. USA 104: 3384-3389.
58. Tang-Feldman, Y. J., G. R. Lochhead, S. R. Lochhead, C. Yu, and C. Pomeroy. 2011. Interleukin-10 repletion suppresses pro-inflammatory cytokines and decreases liver pathology without altering viral replication in murine cytomegalovirus (MCMV)-infected IL-10 knockout mice. Inflamm. Res. 60: 233-243.